Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 30, 2024 10:20am

91 Views

Post# 35960959

Pentagon funding cannabinoid pharmaceutical research

This doesn't even include new classes of cannabinoid based anti-virals, anti-microbials, and anti-bacterials. It's the 'power base' the pulls the strings at the White House and the DEA requires military support for their surveillance capabilities for international trafficking if drugs like opioids and fentanyl.

Published June 28, 2023

The defense bill, called the National Defense Authorization Act, or NDAA, would also require the Pentagon and Department of Veterans Affairs to study the effects of marijuana use in service members and veterans with PTSD, depression, anxiety or chronic pain.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments